Antares Pharma, Inc. (ATRS)

Operating Expenses

$25.61M

Quarterly · Period ending: · USD

ATRS logo

ATRS Operating Expenses

Latest reported$25.61M
ATRS Quarterly Operating Expenses ($0.00 → $25.61M)
High-resolution chart · PNG

ATRS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
25,610,000
41,531,000
23,797,000
21,751,000
20,247,000
18,976,000
17,636,000
16,865,000
19,403,000
18,246,000
19,248,000
17,581,000
17,322,000
14,903,000
11,938,000
11,113,000
11,136,000
10,951,781
11,475,310
10,519,373
10,553,536
11,726,506
11,581,487
10,962,540
13,251,207
12,319,807
11,753,556
11,173,762
11,415,271
13,019,794
11,236,819
13,287,858
12,833,794
10,007,285
8,872,402
7,487,532
5,904,368
8,843,825
5,908,642
4,783,368
4,970,770
3,445,384
3,378,488
3,745,979
3,528,236
3,624,442
3,707,503
3,606,023
3,633,978
3,466,187
3,441,272
3,103,123
3,854,290
3,934,021
3,819,190
4,001,543
4,084,341
3,414,876
3,368,411
3,437,000
2,840,275
2,919,942
2,038,957
2,995,653
2,641,406
2,423,789
2,134,857
2,570,339
2,548,190
2,970,148
2,573,438
2,001,534
2,203,200
3,160,074
2,830,308
2,098,647
2,323,972
4,815,188
2,309,423
2,392,888
2,166,878
3,450,901
2,383,381
2,408,402
1,941,962
1,997,945
1,233,098
1,118,093
1,003,422
707,372
1,400,000
1,300,000
1,500,000
2,344,673
1,700,000
1,500,000
1,500,000
1,335,894
1,500,000
1,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.